AT214929T
The use of 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for manufacture of a medicament for the treatment of helicobacter pylori infections and associated gastroduodenal diseases
Abstract
The invention relates to 7 of 2) oxygen mixing and 5,8) are connected with two mixing (4.3.0) ninth stalk of the quinolone carboxylic acid and naphthyridine ketone of carboxylic acid derivative 8) is groups and bottom substitutions and which can hydrates and/or the amino in the treatment of helicobacter pylori bacillus infection and use with the related duodenoscope stomach disease.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
59 members in 29 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 19652239 | Germany | A | |
| 9706781 | European Patent Office (EPO) | W |
Members59
| Document | Office | Kind | |
|---|---|---|---|
| DE19652239A1 | Germany | A1 | |
| CA2274894A1 | Canada | A1 | |
| WO9826779A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5854198A | Australia | A | |
| NO992903D0 | Norway | D0 | |
| NO992903L | Norway | L | |
| TR199901754T2 | Türkiye | T2 | |
| EP0946176A1 | European Patent Office (EPO) | A1 | |
| EE9900248A | Estonia | A | |
| BG103474A | Bulgaria | A | |
| PL333928A1 | Poland | A1 | |
| CZ216899A3 | Czechia | A3 | |
| CN1245428A | China | A | |
| AU717751B2 | Australia | B2 | |
| BR9714032A | Brazil | A | |
| IL130311D0 | Israel | D0 | |
| EA199900526A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US6133260A | United States of America | A | |
| HU0000450A2 | Hungary | A2 | |
| HUP0000450A2 | Hungary | A2 | |
| JP2000514825A | Japan | A | |
| HK1025517A1 | Hong Kong, China | A1 | |
| KR20000069483A | Republic of Korea | A | |
| JP2000351781A | Japan | A | |
| NZ336228A | New Zealand | A | |
| SK79599A3 | Slovakia | A3 | |
| HU0000450A3 | Hungary | A3 | |
| HUP0000450A3 | Hungary | A3 | |
| NZ506162A | New Zealand | A | |
| EP0946176B1 | European Patent Office (EPO) | B1 | |
| AT214929TThis record | Austria | T | |
| ATE214929T1 | Austria | T1 | |
| DE59706808D1 | Germany | D1 | |
| DK0946176T3 | Denmark | T3 | |
| EA002477B1 | Eurasian Patent Organization (EAPO) | B1 | |
| US6432948B1 | United States of America | B1 | |
| PT946176E | Portugal | E | |
| YU27499A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| ES2175519T3 | Spain | T3 | |
| SK14962000A3 | Slovakia | A3 | |
| SK283223B6 | Slovakia | B6 | |
| SK283224B6 | Slovakia | B6 | |
| UA57055C2 | Ukraine | C2 | |
| EE04090B1 | Estonia | B1 | |
| JP3463939B2 | Japan | B2 | |
| IL130311A | Israel | A | |
| BG64615B1 | Bulgaria | B1 | |
| KR100536153B1 | Republic of Korea | B1 | |
| PL191193B1 | Poland | B1 | |
| CZ297363B6 | Czechia | B6 | |
| CZ297364B6 | Czechia | B6 | |
| CN100335054C | China | C | |
| RS49684B | Serbia | B | |
| NO325617B1 | Norway | B1 | |
| HU226523B1 | Hungary | B1 | |
| CA2274894C | Canada | C | |
| JP2009235106A | Japan | A | |
| JP4463380B2 | Japan | B2 | |
| JP5112395B2 | Japan | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Change in the person of patent ownerEEIH | EEIH |
Numbers
- Application
- 97954354
Titles2
- German
- VERWENDUNG VON 7-(2-OXA-5,8-DIAZABICYCLO 4.3.0)NON-8-YL)-CHINOLONCARBONSÄURE- UND - NAPHTHYRIDONCARBONSÄURE-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR THERAPIE VON HELICOBACTER-PYLORI-INFEKTIONEN UND DEN DAMIT ASSOZIIERTEN GASTRODUODENALEN ERKRANKUNGEN
- English
- USE OF 7- (2-OXA-5,8-DIAZABICYCLO 4.3.0) NON-8-YL) -QUINOLONCARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE THERAPY OF HELICOBACTER PYLORI INFECTIONS AND THE ASSOCIATED GASTRODUODENAL DISEASES THEREOF
Classification
- CPC, 9
- C07D498/04
- A61K31/47
- A61K31/5383
- A61K31/5395
- A61P1/00
- C07D519/00
- A61P1/02
- A61P1/04
- A61P31/04
- IPC, 8
- A61K31 47
- A61K31 4709
- A61K31 5383
- A61K31 5395
- A61P1 04
- A61P31 04
- C07D498 04
- C07D519 00